Inflammation News and Research

RSS

More evidence on why the Mediterranean diet is good for heart

Researchers have discovered one potential mechanism by which briefly cutting off, then restoring, blood flow to arteries prior to a heart attack lessens the damage caused, according to a study published today in the journal Cardiovascular Research.

2 Dec 2008

ViroPharma Inc. submits sBLA for Cinryze to treat acute attacks of hereditary angioedema

ViroPharma Inc. has announced that the company submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for Cinryze C1 Inhibitor (human) as a treatment for acute attacks of hereditary angioedema (HAE).

1 Dec 2008

Poor quality HDL cholesterol bad for you

If you think your levels of "good cholesterol" are good enough, a new study published in the December 2008 issue of The FASEB Journal suggests that you may want to think again.

1 Dec 2008

New imaging technique captures clinical stages of ocular inflammation

Researchers used a new imaging technique to take high quality color photographs of the clinical stages of ocular inflammation in mice, and the technology could help in the monitoring and treatment of diseases of the eye that may cause blindness.

1 Dec 2008

Relief for common and painful heel problem called plantar fasciitis

Combining an ultrasound-guided technique with steroid injection is 95 percent effective at relieving the common and painful foot problem called plantar fasciitis, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).

1 Dec 2008

Etanercept found to be ineffective in treating alcoholic hepatitis

A new study from Mayo Clinic finds the use of the drug therapy etanercept ineffective in treating alcoholic hepatitis, an acute inflammation of the liver caused by excessive consumption of alcohol. The results of the study are published in the December issue of Gastroenterology.

1 Dec 2008

If cold symptoms persist it could be sinusitis

If your stuffy nose and headache last for more than two weeks, it may be more serious than a cold.

1 Dec 2008

Researchers find that when cells shut down they also spew proteins into their surrounding environment

Cells shut down and stop dividing when their DNA is damaged, in a process known as cellular senescence, so as to prevent damaged DNA from leading to unregulated cell division and therefore cancer.

1 Dec 2008

Anadys Pharmaceuticals receives fast track for ANA598 treatment of chronic hepatitis C virus

Anadys Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted fast track designation to ANA598 for the treatment of chronic hepatitis C virus (HCV) infection. ANA598 is Anadys' investigational hepatitis C non-nucleoside polymerase inhibitor.

1 Dec 2008

Blame your genes: why some people get sicker for longer

People with certain high risk gene combinations are eight times more likely to suffer from a severe and prolonged illness when they have an infection, according to University of New South Wales (UNSW) researchers.

1 Dec 2008

Scientists hope European grant can improve healthy ageing

Researchers hope to achieve healthy ageing by enhancing body healing capacity and reducing chronic inflammation.

1 Dec 2008

Research identifies cell receptor as target for anti-inflammatory immune response

Cell reception. By comparing normal mice (left) with mice that are genetically engineered to lack certain receptors in their spleen (right), scientists have shown SIGNR1 receptors (blue) are required to facilitate an anti-inflammatory action.

28 Nov 2008

Breakthrough for dialysis patients

Suffering from end-stage renal disease (ESRD), a growing number of patients at the Centre hospitalier de l'Université de Montréal (CHUM), have become the beneficiaries of a North American breakthrough: high efficacy hemodiafiltration (HDF).

28 Nov 2008

MorphoSys and Galapagos enter alliance to co-develop novel therapeutic antibodies in bone and joint disease

MorphoSys AG and Galapagos NV announced today the launch of a long term co-development alliance aimed at discovering and developing antibody therapies based on novel modes of action in bone and joint disease, including rheumatoid arthritis, osteoporosis and osteoarthritis.

26 Nov 2008

Hormone therapy could be dangerous for women pre-existing heart disease risk factors

Hormone therapy could accentuate certain pre-existing heart disease risk factors and a heart health evaluation should become the norm when considering estrogen replacement, new research suggests.

25 Nov 2008

Presence of gum disease may help dentists and physicians identify risk of cardiovascular disease

Individuals reporting a history of periodontal disease were more likely to have increased levels of inflammation, a risk factor for heart disease, compared to those who reported no history of periodontal disease, according to an American Journal of Cardiology report available online today.

25 Nov 2008

MorphoSys granted U.S. patent on antibodies against GM-CSF to treat inflammatory disorders

MorphoSys AG and the University of Melbourne announced today that the U.S. Patent & Trademark Office (USPTO) has confirmed that it will issue U.S. Patent No. 7,455,836, covering key uses of antibodies against GM-CSF.

25 Nov 2008

Long-term use of a macrolide antibiotic reduce COPD exacerbations, raise questions

Long-term use of a macrolide antibiotic may reduce the frequency of exacerbations in patients with moderate to severe chronic obstructive pulmonary disease (COPD) by as much as 35 percent, according to a London-based study.

21 Nov 2008

FDA accepts filing and grants priority review for DX-88 for hereditary angioedema

Dyax Corp. has announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company's Biologics License Application (BLA) for DX-88 (ecallantide) for the treatment of acute attacks of hereditary angioedema (HAE) and has designated the application for Priority Review.

21 Nov 2008

Light drinking has certain health benefits, researchers look at why

While the physiological damage and social havoc created by alcohol abuse and dependency are well-known, it is also true that light-to-moderate drinking has certain health benefits.

20 Nov 2008

Inflammation News and Research

More evidence on why the Mediterranean diet is good for heart

ViroPharma Inc. submits sBLA for Cinryze to treat acute attacks of hereditary angioedema

Poor quality HDL cholesterol bad for you

New imaging technique captures clinical stages of ocular inflammation

Relief for common and painful heel problem called plantar fasciitis

Etanercept found to be ineffective in treating alcoholic hepatitis

If cold symptoms persist it could be sinusitis

Researchers find that when cells shut down they also spew proteins into their surrounding environment

Anadys Pharmaceuticals receives fast track for ANA598 treatment of chronic hepatitis C virus

Blame your genes: why some people get sicker for longer

Scientists hope European grant can improve healthy ageing

Research identifies cell receptor as target for anti-inflammatory immune response

Breakthrough for dialysis patients

MorphoSys and Galapagos enter alliance to co-develop novel therapeutic antibodies in bone and joint disease

Hormone therapy could be dangerous for women pre-existing heart disease risk factors

Presence of gum disease may help dentists and physicians identify risk of cardiovascular disease

MorphoSys granted U.S. patent on antibodies against GM-CSF to treat inflammatory disorders

Long-term use of a macrolide antibiotic reduce COPD exacerbations, raise questions

FDA accepts filing and grants priority review for DX-88 for hereditary angioedema

Light drinking has certain health benefits, researchers look at why

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News